Marcella Fasso

Title: Marcella Fasso: Innovator in Cancer Treatment

Introduction

Marcella Fasso is a prominent inventor based in Richmond, CA, who has made significant contributions to the field of cancer treatment through her innovative research. With a focus on immunogenic fusion proteins, she has developed methods that aim to elicit immune responses in subjects, showcasing her dedication to advancing medical science.

Latest Patents

Marcella Fasso holds 2 patents that reflect her groundbreaking work. Her latest patents include "Immunogenic fusion proteins for the treatment of cancer," which provides compositions and methods for eliciting an immune response. This patent emphasizes the use of immunogenic fusion proteins and methods involving host cells that contain nucleic acid molecules encoding these proteins. Another notable patent is "Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof." This invention offers nucleic acids, expression systems, and vaccine strains that enable efficient expression and secretion of antigens, ultimately eliciting effective T cell responses.

Career Highlights

Throughout her career, Marcella has worked with esteemed organizations such as Aduro Biotech Inc. and The Johns Hopkins University. Her experience in these institutions has allowed her to collaborate with leading experts in the field, further enhancing her contributions to cancer research.

Collaborations

Marcella has collaborated with notable colleagues, including Dirk G Brockstedt and Peter M Lauer. These partnerships have played a crucial role in her research endeavors and have contributed to the advancement of her innovative projects.

Conclusion

Marcella Fasso's work in the development of immunogenic fusion proteins represents a significant advancement in cancer treatment. Her patents and collaborations highlight her commitment to improving medical outcomes through innovative research.